Changes in glucose metabolism, lipolysis and fat distribution between 3 and 12 months after therapy initiation in antiretroviral-naive HIV-1-infected men randomized to zidovudine/3TC/lopinavir/r or nevirapine/lopinavir/r (MEDICLAS-Metabolic Effects of Different Classes of Antiretrovirals)